里程碑！禾元生物“植物源重组人血清白蛋白”获批上市

Core Viewpoint - He Yuan Bio's plant-derived recombinant human serum albumin (HY1001) has been approved for market launch to treat liver cirrhosis with low serum albumin levels (≤30g/L) [1] Group 1 - The approval was granted by the National Medical Products Administration (NMPA) [1] - HY1001 was previously included in the priority review list by the Center for Drug Evaluation (CDE) in August 2024 [1]